Waleed Hassanein | President and CEO |
Stephen Gordon | CFO |
Brian Johnston | Gilmartin Group |
Bill Plovanic | Canaccord Genuity |
Calvin Chu | Morgan Stanley |
Josh Jennings | Cowen |
Suraj Kalia | Oppenheimer |
Allen Gong | JPMorgan |
Good afternoon, and welcome to TransMedics Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
We will be facilitating a question-and-answer session towards the end of today's call.
As a reminder, this call is being recorded for replay process. I would now like to turn the call over to Brian Johnston from the Gilmartin Group for a few introductory comments.